NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Medical Officer David Lebwohl sold $394K of Intellia Therapeutics, Inc.
Sold$393,720
$164.05Price
2,400Shares
−75%Stake
What NTLA did after the filing
- The stock from Wed, Aug 11 close, $159.70
- −2.8%
- S&P 500, same days
- +0.2%
Measured over 30 trading days, to the Sep 23 close.
Traded Mon, Aug 9. Filed Wed, Aug 11, 12:50 PM ET, during the session. Returns use the Aug 11 close and the Sep 23 close. Not investment advice.